HEMATOPOIETIC

Clinical trials for HEMATOPOIETIC explained in plain language.

Never miss a new study

Get alerted when new HEMATOPOIETIC trials appear

Sign up with your email to follow new studies for HEMATOPOIETIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for controlling a rare blood disorder that raises cancer risk

Disease control Recruiting now

This study is testing if a low dose of the drug sirolimus is safe and can improve blood cell production in adults with RUNX1 familial platelet disorder. This inherited condition causes low platelets, easy bleeding, and a high risk of blood cancers. Researchers will see if the dru…

Matched conditions: HEMATOPOIETIC

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

HEMATOPOIETIC

Get alerted when new HEMATOPOIETIC trials appear

New hope for controlling a rare blood disorder that raises cancer risk